These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17526824)

  • 1. Nonalcoholic fatty liver disease and insulin resistance in youth.
    Bloomgarden ZT
    Diabetes Care; 2007 Jun; 30(6):1663-9. PubMed ID: 17526824
    [No Abstract]   [Full Text] [Related]  

  • 2. Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease.
    Bloomgarden ZT
    Diabetes Care; 2005 Jun; 28(6):1518-23. PubMed ID: 15920084
    [No Abstract]   [Full Text] [Related]  

  • 3. Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease.
    Bianchi G; Bugianesi E; Frystyk J; Tarnow L; Flyvbjerg A; Marchesini G
    Dig Liver Dis; 2011 Jan; 43(1):73-7. PubMed ID: 20554486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is nonalcoholic fatty liver disease in children the same disease as in adults?
    Hsu E; Murray K
    Clin Liver Dis; 2012 Aug; 16(3):587-98. PubMed ID: 22824482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
    Orlik B; Handzlik G; Olszanecka-Glinianowicz M
    Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes.
    Grønbaek H; Thomsen KL; Rungby J; Schmitz O; Vilstrup H
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):705-11. PubMed ID: 19072347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.
    Yilmaz Y; Ulukaya E; Atug O; Dolar E
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1247-51. PubMed ID: 19474742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease.
    Adams LA; Angulo P; Lindor KD
    CMAJ; 2005 Mar; 172(7):899-905. PubMed ID: 15795412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in nonalcholic fatty liver disease.
    Greenfield V; Cheung O; Sanyal AJ
    Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of triglyceride and insulin resistance in patients with nonalcoholic steatohepatitis.
    Basaranoglu M
    Can J Gastroenterol; 2002 Nov; 16(11):813-4; author reply 814. PubMed ID: 12464976
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease in pediatric patients.
    Sinatra FR
    JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):43S-8S. PubMed ID: 22237875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
    Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
    Parekh S; Anania FA
    Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
    Choudhury J; Sanyal AJ
    Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease as a pro-resolution defective disorder.
    Das UN
    Nutrition; 2013 Jan; 29(1):345-9. PubMed ID: 22858195
    [No Abstract]   [Full Text] [Related]  

  • 16. Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.
    Polyzos SA; Kountouras J; Zavos C; Stergiopoulos C
    Med Hypotheses; 2010 Jun; 74(6):1089-90. PubMed ID: 20080361
    [No Abstract]   [Full Text] [Related]  

  • 17. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
    Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
    J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.
    Eguchi Y; Eguchi T; Mizuta T; Ide Y; Yasutake T; Iwakiri R; Hisatomi A; Ozaki I; Yamamoto K; Kitajima Y; Kawaguchi Y; Kuroki S; Ono N
    J Gastroenterol; 2006 May; 41(5):462-9. PubMed ID: 16799888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty liver: cause or consequence.
    Hitman GA
    Diabet Med; 2012 Sep; 29(9):1097. PubMed ID: 22882641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.